» Articles » PMID: 32919754

Cognitive and Behavioural Inhibition Deficits in Neurodegenerative Dementias

Overview
Journal Cortex
Date 2020 Sep 13
PMID 32919754
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Disinhibition, mainly caused by damage in frontotemporal brain regions, is one of the major causes of caregiver distress in neurodegenerative dementias. Behavioural inhibition deficits are usually described as a loss of social conduct and impulsivity, whereas cognitive inhibition deficits refer to impairments in the suppression of prepotent verbal responses and resistance to distractor interference. In this review, we aim to discuss inhibition deficits in neurodegenerative dementias through behavioural, cognitive, neuroanatomical and neurophysiological exploration. We also discuss impulsivity and compulsivity behaviours as related to disinhibition. We will therefore describe different tests available to assess both behavioural and cognitive disinhibition and summarise different manifestations of disinhibition across several neurodegenerative diseases (behavioural variant of frontotemporal dementia, Alzheimer's disease, Parkinson's disease, progressive supranuclear palsy, Huntington's disease). Finally, we will present the latest findings about structural, metabolic, functional, neurophysiological and also neuropathological correlates of inhibition impairments. We will briefly conclude by mentioning some of the latest pharmacological and non pharmacological treatment options available for disinhibition. Within this framework, we aim to highlight i) the current interests and limits of tests and questionnaires available to assess behavioural and cognitive inhibition in clinical practice and in clinical research; ii) the interpretation of impulsivity and compulsivity within the spectrum of inhibition deficits; and iii) the brain regions and networks involved in such behaviours.

Citing Articles

Providing appropriate health and social care for people with dementia or mild cognitive impairment in the criminal justice system of England and Wales: a thematic analysis of prisoner and staff interview data.

ONeill A, Heathcote L, Archer-Power L, Ware S, Shaw J, Senior J Health Justice. 2025; 13(1):5.

PMID: 39831914 PMC: 11744824. DOI: 10.1186/s40352-024-00313-5.


rTMS Modulation of Behavioral and Biological Measures in 3xTg-AD Mice.

Kraybill E, Mojabi F, Heath A, Spikes C, Beard C, McNerney M Brain Sci. 2025; 14(12).

PMID: 39766385 PMC: 11674534. DOI: 10.3390/brainsci14121186.


Pharmacological inhibition of PLK2 kinase activity mitigates cognitive decline but aggravates APP pathology in a sex-dependent manner in APP/PS1 mouse model of Alzheimer's disease.

Martinez-Drudis L, Berard M, Musiol D, Rivest S, Oueslati A Heliyon. 2024; 10(20):e39571.

PMID: 39498012 PMC: 11532864. DOI: 10.1016/j.heliyon.2024.e39571.


Multimodal nonlinear correlates of behavioural symptoms in frontotemporal dementia.

Zamboni G, Mattioli I, Arya Z, Tondelli M, Vinceti G, Chiari A Brain Imaging Behav. 2024; 18(5):1226-1238.

PMID: 39243355 PMC: 11582133. DOI: 10.1007/s11682-024-00913-7.


Go/No-Go Ratios Modulate Inhibition-Related Brain Activity: An Event-Related Potential Study.

Zhang N, An W, Yu Y, Wu J, Yang J Brain Sci. 2024; 14(5).

PMID: 38790393 PMC: 11117662. DOI: 10.3390/brainsci14050414.


References
1.
Logan G, Van Zandt T, Verbruggen F, Wagenmakers E . On the ability to inhibit thought and action: general and special theories of an act of control. Psychol Rev. 2014; 121(1):66-95. DOI: 10.1037/a0035230. View

2.
Borges L, Rademaker A, Bigio E, Mesulam M, Weintraub S . Apathy and Disinhibition Related to Neuropathology in Amnestic Versus Behavioral Dementias. Am J Alzheimers Dis Other Demen. 2019; 34(5):337-343. PMC: 7256964. DOI: 10.1177/1533317519853466. View

3.
Mendez M, Perryman K, Miller B, Cummings J . Behavioral differences between frontotemporal dementia and Alzheimer's disease: a comparison on the BEHAVE-AD rating scale. Int Psychogeriatr. 1998; 10(2):155-62. DOI: 10.1017/s1041610298005262. View

4.
Matias-Guiu J, Cabrera-Martin M, Valles-Salgado M, Rognoni T, Galan L, Moreno-Ramos T . Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer's disease: clinical assessment and metabolic correlates. Brain Imaging Behav. 2018; 13(3):651-659. DOI: 10.1007/s11682-018-9891-3. View

5.
Bodden M, Dodel R, Kalbe E . Theory of mind in Parkinson's disease and related basal ganglia disorders: a systematic review. Mov Disord. 2009; 25(1):13-27. DOI: 10.1002/mds.22818. View